JYNT · JOINT Corp · Metrics
Market Cap
$111.02M
Shares
14.14M
JYNT metrics
77 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$7.85
Market cap
$111.02M
Price action
20 metricsPrice change (1W)
-5.6%
Price change (30D)
-7.1%
Price change (3M)
-18.1%
Price change (6M)
-6.5%
Price change (YTD)
-10.0%
Price change (1Y)
-23.0%
Trailing year
Price change (5Y)
-92.6%
52-week high
$10.53
52-week low
$7.67
Change from 52-week high
-25.5%
Change from 52-week low
+2.3%
Annualized volatility
36.1%
Annualized volatility (3M)
35.0%
Beta
0.8
RSI (14D)
31.7
Price vs SMA 50
-7.9%
Price vs SMA 200
-10.9%
Avg volume (3M)
104,082
Relative volume
0.9
Average dollar volume
$900,471
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
14.14M
Valuation
12 metricsP / E (TTM)
29.1
Trailing earnings · reciprocal yield 3.4%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 52.7%
P / book
7.0
reciprocal yield 14.3%
FCF yield
3.8%
TTM · current market cap
Buyback yield
11.8%
P / FCF
26.3
reciprocal yield 3.8%
P / operating cash flow
20.6
reciprocal yield 4.9%
Earnings yield
3.4%
Historical valuation
8 metricsP / E historical average (3Y)
44.6×
reciprocal yield 2.2%
P / E historical average (5Y)
182.6×
reciprocal yield 0.5%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
11.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
81.8%
Operating margin
2.4%
Trailing 12 months
Net margin
6.5%
Gross profit (TTM)
—
Operating profit (TTM)
$1.41M
Net income (TTM)
$3.80M
Trailing 12 months
Diluted EPS (TTM)
$0.27
FCF margin
7.2%
Effective tax rate
1.6%
Growth
11 metricsRevenue growth YoY
+14.4%
Year over year
Net income growth YoY
+599.4%
Revenue (TTM)
$58.55M
Trailing 12 months
EPS growth YoY
+400.0%
Shares change YoY
-7.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-18.5%
Revenue CAGR (5Y)
-1.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-26.7%
FCF CAGR (3Y)
-47.5%
FCF CAGR (5Y)
-47.0%
Quality
14 metricsReturn on equity
24.0%
Return on assets
7.4%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
$3.12M
Free cash flow (TTM)
$4.23M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$22.16M
Total assets
$51.63M
Total debt
$100,000
Cash flow & spend
7 metricsOperating cash flow (TTM)
$5.39M
Capital expenditures (TTM)
$1.16M
R&D (TTM)
—
SG&A (TTM)
$46.23M
Stock compensation (TTM)
$1.38M
R&D / revenue
—
Stock compensation / revenue
2.3%
Ownership (13F)
3 metrics13F filers
82
13F filer change QoQ
-4
Institutional ownership
68.4%
Short interest
3 metricsShort interest
2.8%
Latest settlement · 6.9 days to cover
Days to cover
6.9d
Short-squeeze score
54 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1612630
CUSIP
47973J102
13F (30d)
24 filings
24 filers
Visit website
Investor relations